Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)
Phase 2
Recruiting
- Conditions
- COVID-19
- Interventions
- Biological: SARS-COV-2 Vaccine (Vero Cell-Sinopharm) Inactivated
- First Posted Date
- 2021-12-29
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 600
- Registration Number
- NCT05172193
- Locations
- 🇮🇩
Bali Mandara Hospital, Denpasar, Bali, Indonesia
🇮🇩Kimia Farma Diponegoro Clinic and Laboratorium, Bandung, West Java, Indonesia
🇮🇩JIH Hospital, Sleman, D.I. Yogyakarta, Indonesia
The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine
Active, not recruiting
- Conditions
- COVID-19
- Interventions
- Biological: SARS-CoV-2 vaccine (Vero cell) inactivated
- First Posted Date
- 2021-11-19
- Last Posted Date
- 2022-09-08
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 435
- Registration Number
- NCT05126550
- Locations
- 🇮🇩
Laboratorium Klinik Kimia Farma Cikini, Jakarta, Indonesia
🇮🇩Laboratorium Klinik Kimia Farma Sutomo Semarang, Semarang, Indonesia
🇮🇩Laboratorium Klinik Kimia Farma Diponegoro Bandung, Bandung, Indonesia
Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject
Not Applicable
Completed
- Conditions
- Drug Use
- Interventions
- First Posted Date
- 2021-08-03
- Last Posted Date
- 2023-02-09
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 56
- Registration Number
- NCT04988646
- Locations
- 🇮🇩
PT Pharma Metric Labs, Jakarta Pusat, DKI Jakarta, Indonesia
Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers
Not Applicable
Completed
- Conditions
- Drug Use
- Interventions
- First Posted Date
- 2021-07-29
- Last Posted Date
- 2023-11-02
- Lead Sponsor
- PT. Kimia Farma (Persero) Tbk
- Target Recruit Count
- 24
- Registration Number
- NCT04982874
- Locations
- 🇮🇩
PT Pharma Metric Labs, Jakarta Pusat, DKI Jakarta, Indonesia
© Copyright 2025. All Rights Reserved by MedPath